Oral SARS-CoV-2 host responses predict the early COVID-19 disease course

被引:0
|
作者
Seaman, William T. [1 ,2 ]
Keener, Olive [2 ,3 ]
Nanayakkara, Dinelka [4 ]
Mollan, Katie R. [5 ,6 ]
Premkumar, Lakshmanane [7 ]
Cuadra, Edwing Centeno [7 ]
Jones, Corbin D. [5 ,8 ]
Pettifor, Audrey [5 ,6 ]
Bowman, Natalie M. [5 ]
Wang, Frank [9 ]
Webster-Cyriaque, Jennifer [1 ,2 ,5 ,10 ]
机构
[1] Natl Inst Allergy & Infect Dis, NIH, Bethesda, MD 20892 USA
[2] Univ N Carolina, Div Oral & Craniofacial Hlth Sci, Chapel Hill, NC 27599 USA
[3] North Carolina Sch Math & Sci, Durham, NC USA
[4] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA
[5] Univ N Carolina, UNC Sch Med, 111 Mason Farm Rd,Med Biomol Res Bldg,Room 2341b, Chapel Hill, NC 27599 USA
[6] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA
[7] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA
[8] Univ N Carolina, Dept Biol, Chapel Hill, NC USA
[9] Biomedomics Inc, Morrisville, NC USA
[10] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA
来源
SCIENTIFIC REPORTS | 2024年 / 14卷 / 01期
基金
美国国家卫生研究院;
关键词
D O I
10.1038/s41598-024-67504-w
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Oral fluids provide ready detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and host responses. This study sought to evaluate relationships between oral virus, oral and systemic anti-SARS-CoV-2-specific antibodies, and symptoms. Oral fluids (saliva/throat wash (saliva/TW)) and serum were collected from asymptomatic and symptomatic, nasopharyngeal (NP) SARS-CoV-2 RT-qPCR+ human participants (n = 45). SARS-CoV-2 RT-qPCR and N-antigen detection by immunoblot and lateral flow assay (LFA) were performed. RT-qPCR for subgenomic RNA (sgRNA) was sequence confirmed. SARS-CoV-2-anti-S protein RBD LFA and ELISA assessed IgM and IgG responses. Structural analysis identified host salivary molecules analogous to SARS-CoV-2-N-antigen. At time of enrollment (baseline, BL), LFA-detected N-antigen in 86% of TW and was immunoblot-confirmed. However, only 3/17 were saliva/TW qPCR+ . Sixty percent of saliva and 83% of TW demonstrated persistent N-antigen at 4 weeks. N-antigen LFA signal in three anti-spike sero-negative participants suggested potential cross-detection of 4 structurally analogous salivary RNA binding proteins (alignment 19-29aa, RMSD 1-1.5 Angstroms). At enrollment, symptomatic participants demonstrated replication-associated sgRNA junctions, were IgG+ (94%/100% in saliva/TW), and IgM+ (63%/54%). At 4 weeks, SARS-CoV-2 IgG (100%/83%) and IgM (80%/67%) persisted. Oral and serum IgG correlated 100% with NP+ PCR status. Cough and fatigue severity (p = 0.010 and 0.018 respectively), and presence of weakness, nausea, and composite upper respiratory symptoms (p = 0.037, 0.005, and 0.017, respectively) were negatively associated with saliva IgM but not TW or serum IgM. Throat wash IgM levels were higher in women compared to men, although the association did not reach statistical significance (median: 290 (female) versus 0.697, p = 0.056). Important to transmission and disease course, oral viral replication and persistence showed clear relationships with select symptoms and early oral IgM responses during early infection. N-antigen cross-reactivity may reflect mimicry of structurally analogous host proteins.
引用
收藏
页数:18
相关论文
共 50 条
  • [11] Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
    Deshpande, Gururaj Rao
    Sapkal, Gajanan N.
    Tilekar, Bipin N.
    Yadav, Pragya D.
    Gurav, Yogesh
    Gaikwad, Shivshankar
    Kaushal, Himanshu
    Deshpande, Ketki S.
    Kaduskar, Ojas
    Sarkale, Prasad
    Baradkar, Srikant
    Suryawanshi, Annasaheb
    Lakra, Rajen
    Sugunan, A. P.
    Balakrishnan, Anukumar
    Abraham, Priya
    Salve, Pavan
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2020, 152 (01) : 82 - 87
  • [12] Antibody responses against SARS-CoV-2 in COVID-19 patients
    Liu, Anding
    Li, Ying
    Peng, Jing
    Huang, Yuancheng
    Xu, Dong
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (01) : 144 - 148
  • [13] Editorial: SARS-CoV-2 Vaccine Responses and Breakthrough COVID-19
    Parums, Dinah, V
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [14] Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19
    Bridges, James P.
    Vladar, Eszter K.
    Huang, Hua
    Mason, Robert J.
    THORAX, 2022, 77 (02) : 203 - 209
  • [15] Association of Lupus Anticoagulant status with Disease Course in SARS-CoV-2 (COVID-19) Infection
    Woo, Suhyeon
    Kim, Bohyun
    Heo, Nam Hun
    Kim, Min-Sun
    Yoon, Young Ahn
    Choi, Young-Jin
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [16] Association of Lupus Anticoagulant status with Disease Course in SARS-CoV-2 (COVID-19) Infection
    Woo, Suhyeon
    Kim, Bohyun
    Heo, Nam Hun
    Kim, Min-sun
    Yoon, Young Ahn
    Choi, Young-Jin
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [17] The impact of SARS-CoV-2 immunization on COVID-19 disease course in people with myasthenia gravis
    Bakirtzis, Christos
    Boziki, Marina-Kleopatra
    Karakasi, Maria-Valeria
    Moysiadis, Theodoros
    Grigoriadis, Nikolaos
    MUSCLE & NERVE, 2023, 67 (05) : 412 - 416
  • [18] Understanding the Host Innate Immune Responses against SARS-CoV-2 Infection and COVID-19 Pathogenesis
    Kang, Yeon-Woo
    Park, Subin
    Lee, Kun-Joo
    Moon, Dain
    Kim, Young-Min
    Lee, Seung-Woo
    IMMUNE NETWORK, 2021, 21 (01) : 1 - 16
  • [19] The host immune responses to SARS-CoV-2 and therapeutic strategies in the treatment of COVID-19 cytokine storm
    Aliyu, Mansur
    Mozhgani, Sayed-Hamidreza
    Gargari, Omid Kohandel
    Yusuf, Mustapha Ahmed
    Saboor-Yaraghi, Ali Akbar
    AIMS ALLERGY AND IMMUNOLOGY, 2021, 5 (04): : 240 - 258
  • [20] Focus on SARS-CoV-2 and COVID-19
    Chen, Sharon C-A.
    Rawlinson, William D.
    PATHOLOGY, 2020, 52 (07) : 743 - 744